Clinical Trials Directory

Trials / Completed

CompletedNCT04206150

The Appropriate Level of Continuous Adductor Canal Block in Patients Undergoing Total Knee Arthroplasty (TKA)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
96 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

Adductor canal catheters are being used to provide continuous postoperative analgesia after total knee arthroplasty surgery (TKA). There is much debate about where is the best position of continuous adductor canal block in patients undergoing TKA. Therefore, the investigators aim to compare the postoperative pain at three different level of continuous adductor canal block. Ninety six patients scheduled for total knee arthroplasty will be randomly divided into the three groups. In group 1, the adductor canal catheter is inserted at femoral triangle apex (the proximal end of the adductor canal). In group 2, the adductor canal catheter is inserted femur length/15\*2 cm above the location where the nerve block performed in group 1. In group 3, the adductor canal catheter is inserted femur length/15cm below the location where the nerve block performed in group 1.

Conditions

Interventions

TypeNameDescription
PROCEDUREthe three different sites of continous adductor canal block: the adductor canal catheter is inserted at femoral triangle apexIn group 1, the adductor canal catheter is inserted at femoral triangle apex (the proximal end of the adductor canal).
PROCEDUREthe three different sites of continous adductor canal block: the adductor canal catheter is inserted femur length/15*2 cm above the locationIn group 2, the adductor canal catheter is inserted femur length/15\*2 cm above the location where the nerve block performed in group 1.
PROCEDUREthe three different sites of continous adductor canal block: the adductor canal catheter is inserted femur length/15 cm below the locationIn group 3, the adductor canal catheter is inserted femur length/15 cm below the location where the nerve block performed in group 1.

Timeline

Start date
2020-04-02
Primary completion
2021-07-16
Completion
2021-07-17
First posted
2019-12-20
Last updated
2021-10-15

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04206150. Inclusion in this directory is not an endorsement.